Why the study?
Do thrombolytic agents improve myocardial salvage and reduce mortality in patients with acute myocardial infarction?
Do thrombolytic agents improve myocardial salvage and reduce mortality in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Thrombolytic therapy is an effective treatment for acute myocardial infarction that improves myocardial salvage and reduces mortality, though individual risk-to-benefit ratios must be considered.
The underlying cause of acute myocardial infarction can now be effectively treated with thrombolytic agents, thereby increasing myocardial salvage and reducing mortality. Clinicians should always be aware of the risk-to-benefit ratio in treating patients with thrombolytic agents and treat each patient on an individual basis.
No takes yet. Share an insight, caveat, or question.
Ro et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: